OGN – organon & co. (US:NASDAQ)
Stock Stats
News
Organon & Co. (NYSE:OGN) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
Organon & Co. (NYSE:OGN) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $7.50 price target on the stock.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Form 4 Organon & Co. For: Nov 13 Filed by: Drinane Juliana Papa
Form 4 Organon & Co. For: Nov 13 Filed by: Morrissey Joseph T. Jr.
Form 4 Organon & Co. For: Nov 07 Filed by: Drinane Juliana Papa
Form 3 Organon & Co. For: Oct 27 Filed by: Drinane Juliana Papa
Form 4 Organon & Co. For: Nov 07 Filed by: Arjona Ferreira Juan Camilo
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.